Trimethoprim (Page 3 of 3)


  1. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. 3rd ed.: Approved Standard. NCCLS Document M7-A3. Vol. 13. No. 25. Villanova. Pa: NCCLS: 1993.

  2. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk Susceptibility Tests. 5th ed.: Approved Standard. NCCLS Document M2-A5. Vol. 13. No. 24. Villanova. Pa: NCCLS: 1993.

  3. Brumfitt W, Pursell R. Trimethoprim-sulfamethoxazole in the treatment of bacteriuria in women. J Infect Dis. 1973;128(suppl):S657-S663.

Manufactured by:
Danbury, CT 06810

Rev: April 2000

trimethoprim tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0591-5571
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
Trimethoprim (Trimethoprim) Trimethoprim 100 mg
Inactive Ingredients
Ingredient Name Strength
anhydrous lactose
collodial silicon dioxide
magnesium searate
sodium lauryl sulfate
sodium starch glycolate
stearic acid
Product Characteristics
Color WHITE Score 2 pieces
Shape OVAL Size 9mm
Flavor Imprint Code DAN;DAN;5571
Coating false Symbol false
# Item Code Package Description Multilevel Packaging
1 NDC:0591-5571-01 100 TABLET (100 TABLET) in 1 BOTTLE None
Labeler — Watson Labs

Revised: 01/2007 Watson Labs

Page 3 of 3 1 2 3

All resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2022. All Rights Reserved.